Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Taletrectinib

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nuvation Bio Initiates First Patient Enrollment In Ibtrozi
    Nuvation Bio Initiates First Patient Enrollment In Ibtrozi

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929100711/en/Nuvation-Bio-Enrolls-First-Patient-in-TRUST-IV-Phase-3-Study-of-IBTROZI-taletrectinib-for-the-Adjuvant-Treatment-of-ROS1-Positive-Early-Stage-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Nuvation Bio Gets Japan Nod for IBTROZITM in Advanced ROS1+ NSCLC
    Nuvation Bio Gets Japan Nod for IBTROZITM in Advanced ROS1+ NSCLC

    19 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250918983094/en/Nuvation-Bio-Receives-Approval-from-Japans-Ministry-of-Health-Labour-and-Welfare-for-IBTROZITM-for-Patients-with-Advanced-ROS1-positive-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    19 Sep 2025
    Share Share
    Nuvation Announces Data from Pivotal Clinical Studies of Ibtrozi
    Nuvation Announces Data from Pivotal Clinical Studies of Ibtrozi

    07 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250907734789/en/Nuvation-Bio-Announces-New-Data-from-Pivotal-Clinical-Studies-of-IBTROZI-taletrectinib-in-Advanced-ROS1-Positive-Non-Small-Cell-Lung-Cancer-at-2025-World-Conference-on-Lung-Cancer

    BUSINESSWIRE
    07 Sep 2025
    Share Share
    Nuvation Bio Reveals New IBTROZI Data at WCLC and ESMO Congresses
    Nuvation Bio Reveals New IBTROZI Data at WCLC and ESMO Congresses

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805634510/en/Nuvation-Bio-To-Present-New-Data-on-IBTROZI-taletrectinib-in-Advanced-ROS1-Positive-Non-Small-Cell-Lung-Cancer-at-WCLC-and-ESMO-Annual-Congresses

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Taletrectinib Added to NCCN Guidelines for ROS1+ NSCLC Cancer
    Taletrectinib Added to NCCN Guidelines for ROS1+ NSCLC Cancer

    24 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250624605890/en/Nuvation-Bio-Announces-National-Comprehensive-Cancer-Network-Adds-Taletrectinib-IBTROZI-as-Preferred-Option-to-Clinical-Practice-Guidelines-in-Oncology-for-Advanced-ROS1-Non-Small-Cell-Lung-Cancers

    BUSINESSWIRE
    24 Jun 2025
    Share Share
    Onco360 Selected as National Specialty Pharmacy for Ibtrozi™
    Onco360 Selected as National Specialty Pharmacy for Ibtrozi™

    16 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/16/3099726/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-IBTROZI-taletrectinib-Manufactured-by-Nuvation-Bio-Inc.html

    GLOBENEWSWIRE
    16 Jun 2025
    Share Share